Recent evidence from clinicopathological analyses has strengthened the signature by correlating elevated RNA-editing level of AZIN1 with the risk of liver cirrhosis, tumor recurrence, and worse prognosis [33]. This evidence concerns the gene AZIN1 and neoplasm.